D.E. Shaw & Co’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,373
Closed -$171K 4714
2025
Q2
$171K Buy
+11,373
New +$166K ﹤0.01% 4074
2025
Q1
Sell
-41,543
Closed -$599K 4442
2024
Q4
$599K Sell
41,543
-51,734
-55% -$924K ﹤0.01% 3506
2024
Q3
$1.82M Sell
93,277
-6,261
-6% -$113K ﹤0.01% 2773
2024
Q2
$1.7M Sell
99,538
-40,935
-29% -$755K ﹤0.01% 2795
2024
Q1
$2.36M Sell
140,473
-23,133
-14% -$351K ﹤0.01% 2497
2023
Q4
$2.96M Buy
163,606
+34,555
+27% +$628K ﹤0.01% 2345
2023
Q3
$2.19M Buy
129,051
+193
+0.1% +$2.77K ﹤0.01% 2493
2023
Q2
$1.55M Sell
128,858
-16,201
-11% -$221K ﹤0.01% 2810
2023
Q1
$1.89M Sell
145,059
-95,797
-40% -$1.57M ﹤0.01% 2732
2022
Q4
$3.56M Buy
+240,856
New +$2.63M ﹤0.01% 2406
2021
Q4
Sell
-32,364
Closed -$1.19M 5521
2021
Q3
$1.19M Buy
32,364
+25,202
+352% +$991K ﹤0.01% 3472
2021
Q2
$281K Sell
7,162
-19,408
-73% -$560K ﹤0.01% 4311
2021
Q1
$751K Sell
26,570
-5,867
-18% -$187K ﹤0.01% 3297
2020
Q4
$1.04M Buy
+32,437
New +$997K ﹤0.01% 3000

Other funds holding HCM

D.E. Shaw & Co's HCM Position: Q3 2025 in Review

D.E. Shaw & Co sold out of HUTCHMED (HCM) in Q3 2025, closing a stake of 11,373 shares — an estimated $171K sold.

D.E. Shaw & Co first reported a position in HCM in Q4 2020 and held it in 14 quarters. The position peaked at $3.56M in Q4 2022. 58 funds tracked by Wall St. Rank hold HCM as of Q3 2025.

  • D.E. Shaw & Co reported no remaining HUTCHMED position as of Q3 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 11,373 HUTCHMED shares in Q3 2025, an estimated $171K.
  • D.E. Shaw & Co first reported a position in HUTCHMED in Q4 2020 and held it in 14 quarters.
  • D.E. Shaw & Co's HUTCHMED position peaked at $3.56M in Q4 2022.
  • 58 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.